Navigation Links
HIV Drug Combo can Boost Immune Marker in Long-term Patients: Study

Patients who successfully respond to drugs that combat the AIDS virus can see a key marker of immune health rebound to a level enjoyed by people without HIV, a study published online Wednesday by The Lancet says.

The paper sheds light on poorly understood conditions as to why some people on antiretroviral drugs can boost and maintain their CD4 immune cells, others see a slower increase in these key defenders while other individuals fail, sometimes tragically so.

Investigators led by Amanda Mocroft of London's Royal Free Centre for HIV Medicine looked at 1,835 people with the human immunodeficiency virus (HIV) before and after they were put on antiretrovirals.

On average, these individuals had a CD4 count of 204 cells per microlitre of blood at the start of the study.

In the first year of taking antiretrovirals, there was a big spurt in the CD4 count, of around 100 cells per microlitre on average.

HIV levels were also suppressed, to below 50 copies of the virus per microlitre, which is considered a key goal in antiretroviral treatment.

Over the next few years, lower -- but still significant -- improvements in the CD4 count continued.

In fact, after three years, patients who had started therapy with a CD4 count of more than 350 cells per microlitre had a CD4 count "approaching the level seen in HIV-negative individuals," Mocroft says.

On average, the boost was around 50 cells per microlitre annually, and this continued even up to the fifth year of treatment, which by the standards of HIV therapy is a long time indeed.

Most rewarding of all was that this enduring improvement was seen among patients who had had low CD4 cells (of less than 200 cells per microlitre) before they began therapy.

Those who began with more than 500 CD4 cells per microlitre saw the least relative improvement.

The upturn in CD4 cells only occu rs, though, if patients continue to respond well to the drugs and can keep their HIV count to below 50 copies per microlitre, the authors warn.

CD4 cells are frontline guardians of the immune system and their levels are closely watched barometers of a patient's ability to fight off opportunistic disease and death.

Previous research in this field has been more pessimistic, suggesting that CD4 counts tend to plateau after several years of treatment.

But those studies used less strict criteria for determining whether the drugs were working.

Their benchmark was a viral load -- the number of AIDS viruses in the blood -- of 1,000 and 400 copies per microlitre, whereas the new study sets a far tougher standard of 50 copies or less.

The paper is published by The Lancet ahead of a meeting in Sydney from Sunday to July 25 of the International AIDS Society, which will focus especially on HIV treatment.


'"/>




Related medicine news :

1. Drug Combo Works Better for children with ADHD, Tics
2. Scanning Combo Helps Detect Lung Cancer
3. Relief From Asthma With New Combo Therapy
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Drug Combo Improves Performance Of Multiple Sclerosis Drug
6. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
7. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
8. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
9. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
10. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
11. Fuzeon and MK-0518 Combo Holds Promise For HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... ... luxurious collection of unique masks and serums that perfectly fuse the beauty of ... advancements, at the 2017 Indie Beauty Expo on August 23rd & 24th in ...
(Date:8/22/2017)... ... 2017 , ... The old adage “you are what you ... healthy foods. But this well-known piece of nutrition advice ignores that an individual’s ... not only on properties of the food but also on properties of the ...
(Date:8/22/2017)... , ... August 22, 2017 , ... ... pleased to announce the addition of Zack Tisch as the firm’s new Consulting ... KLAS-ranked healthcare IT consulting firm’s national accounts, from assisting clients with initial vendor ...
(Date:8/22/2017)... CA (PRWEB) , ... August 22, 2017 , ... ... cycle management (RCM) solutions, announced recently the availability of a new professional fee ... in appreciation for their service to the healthcare industry. E/M coding is complex ...
(Date:8/22/2017)... DFW Metroplex, TX (PRWEB) , ... August 22, 2017 , ... Five Star Glass is ... They provide repair and replacement of auto glass for most makes and models, in ... area in the USA. , They have been a family owned business for the ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
(Date:8/2/2017)... -- CaryRx, a next-generation full-service pharmacy, has announced the launch ... the Washington D.C. metropolitan area. CaryRx ... of medications through the convenience of its patient-friendly mobile app. ... one hour to any location in D.C. ... service to Washington D.C. ," says Areo ...
(Date:7/28/2017)... CHICAGO, July 28, 2017 Hill-Rom Holdings, Inc. ... fiscal third quarter ended June 30, 2017, and updated ... For the fiscal third quarter, ... to $0.68 per diluted share in the prior-year period. ... of $0.39 per diluted share primarily related to the ...
Breaking Medicine Technology: